1-3 of 3
Alfonso Gómez-Pineda, MD
Close
Sort by
Journal Articles

Long Term Results of Non-Myeloablative Stem Cell Transplantation in Non-Hodgkin’s Lymphomas: FLU150/MEL80 (Madrid Protocol).

Jorge Gayoso, MD, Pascual Balsalobre, Jose F. Tomás, PhD, Javier de la Serna, PhD, David Serrano, MD, Rafael Carrión, PhD, Ismael Buño, PhD, Alfonso Gómez-Pineda, MD, Jose L. Díez-Martín, PhD
Journal: Blood
Blood (2007) 110 (11): 5047.
https://doi.org/10.1182/blood.V110.11.5047.5047
Published: 2007
Journal Articles

The Different Dynamics of Chimerism Evolution Determines the Success of Myeloablative, Reduced Intensity Conditioning and T-Cell Depleted Allogeneic Stem Cell Transplantation.

Ismael Buño, PhD, Pascual Balsalobre, Ainhoa Simón, Gustavo Iglesias, Cintia Manzano, Rafael Carrión, MD, PhD, David Serrano, MD, Alfonso Gómez-Pineda, MD, José L. Díez-Martín, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 5288.
https://doi.org/10.1182/blood.V106.11.5288.5288
Published: 2005
Journal Articles

Mixed Chimerism in T Cells after Allogeneic SCT Allows Early Diagnosis of Graft Rejection and Successful Treatment with Immunosuppression Withdrawal and/or Donor Leukocyte Infusion.

Ismael Buño, PhD, Pascual Balsalobre, Ainhoa Simón, Cintia Manzano, Diana Barroso, David Serrano, MD, Rafael Carrión, MD, PhD, Alfonso Gómez-Pineda, MD, José L. Díez-Martín, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 5289.
https://doi.org/10.1182/blood.V106.11.5289.5289
Published: 2005